I note with interest that a director of CRS, R. Berven added to his holdings recently (6/12/02) through the acquisition of an additional 80,000 shares at an average price of 83 cents.
The stock is holding up well and is still in uptrend.
As a long term holder of CRS I see no reason to sell as I believe, for patient holders, the rewards will be forthcoming.
2003 should be a good year for CRS shareholders.
director buying
Add CRS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.0¢ |
Change
0.003(11.1%) |
Mkt cap ! $4.028M | |||
| Open | High | Low | Value | Volume |
| 2.5¢ | 3.0¢ | 2.5¢ | $20.97K | 748.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 500000 | 2.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.9¢ | 300000 | 1 |
View Market Depth
| Last trade - 10.20am 01/12/2023 (20 minute delay) ? |
|
|||||
|
Last
3.0¢ |
Change
0.003 ( 15.4 %) |
||||
| Open | High | Low | Volume | ||
| 2.8¢ | 3.0¢ | 2.8¢ | 155700 | ||
| Last updated 10.16am 01/12/2023 ? | |||||
| CRS (ASX) Chart |